Osteoporosis: Integrating biomarkers and other diagnostic correlates into the management of bone fragility

Alternative Medicine Review

Volumn 12, Issue 2, 2007, Pages 113-145

  McCormick, R Keith ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MILK PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; POTASSIUM; PRASTERONE; SOMATOMEDIN C; THIOCTIC ACID; VITAMIN K GROUP;

BONE DENSITY; BONE FRAGILITY; BONE MASS; BONE REMODELING; FRACTURE; HUMAN; HYPERCALCIURIA; IMMUNE SYSTEM; INFLAMMATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; REVIEW;

ACIDOSIS; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; C-REACTIVE PROTEIN; CALCIUM; CELIAC DISEASE; DEHYDROEPIANDROSTERONE; DENSITOMETRY, X-RAY; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYDROCORTISONE; HYPERHOMOCYSTEINEMIA; MALE; OSTEOPOROSIS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; THYROID DISEASES; VITAMIN D; VITAMIN K;

EID: 34547398674     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Chrischilles EA, Butler CD, Davis CS, Wallace RB. A model of lifetime osteoporosis impact. Arch Intern Med 1991;151:2026-2032.
2. National Health and Nutrition Examination Survey III, 1988-94. U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Hyattsville, MD; 1998.
3. Tosteson A, Solomon D, King AB, et al. Projections of osteoporosis fractures and costs by skeletal site in the USA. J Bone Miner Res 2005;20:S21.
4. Gabriel SE, Tosteson AN, Leibson CL, et al. Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 2002;13:323-330.
5. Reid IR. Therapy of osteoporosis: calcium, vitamin D, and exercise. Am J Med Sci 1996;312:278-286.
6. Prince RL, Devine A, Dhaliwal SS, Dick IM. Results of a 5 year double blind, placebo controlled trial of calcium supplementation (CAIFOS): clinical fracture outcomes. J Bone Miner Res 2004;19:S3.
7. Reid IR, Ames RW, Evans MC, et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 1995;98:331-335.
8. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-683.
9. Finkelstein JS. Calcium plus vitamin D for postmenopausal women - bone appetit? N Engl J Med 2006;354:750-752.
10. Babraj JA, Smith K, Cuthbertson DJ, et al. Human bone collagen synthesis is a rapid, nutritionally modulated process. J Bone Miner Res 2005;20:930-937.
11. Raisz LG, Seeman E. Causes of age-related bone loss and bone fragility: an alternative view. J Bone Miner Res 2001;16:1948-1952.
12. Luo ZC, Fraser WD, Julien P, et al. Tracing the origins of "fetal origins" of adult diseases: programming by oxidative stress? Med Hypotheses 2006;66:38-44.
13. Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-1503.
14. Lips P, Courpron P, Meunier PJ. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res 1978;26:13-17.
15. Riggs BL, Wahner HW, Melton LJ 3rd, et al. Rate of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest 1986;77:1487-1491.
16. Slemenda C, Longscope C, Peacock M, et al. Sex steroids, bone mass and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 1996;97:14-21.
17. Kohlstadt I. Scientific Evidence for Musculoskeletal, Bariatric, and Sports Nutrition. Boca Raton, FL: CRC Press; 2006:27-41.
18. Pocock NA, Eisman JA, Hopper JL, et al. Genetic determinants of bone mass in adults. A twin study. J Clin Invest 1987;80:706-710.